Approval · Notice of Compliance 29779 · 2022
NEXGARD COMBO: Notice of Compliance 29779
Issued December 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29779
- Date
- December 28, 2022
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the CAUTIONS and the ANIMAL SAFETY sections of the label.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXGARD COMBO | Not yet assigned | — |
Medicinal ingredients
- PRAZIQUANTEL 83 MG per ML
- EPRINOMECTIN 4 MG per ML
- ESAFOXOLANER 12 MG per ML